According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
Celebrating the People of Gleneagles Hong Kong
Acibadem Powers Africa’s Premier Football Tournament
Gleneagles JPMC Supports the Children Cancer Foundation
Extending its corporate giving efforts, Gleneagles JPMC presented a cash donation of BND10,000 during its visit to the Yayasan Kanser Kanak-Kanak (YASKA).
Gleneagles Hospital Johor Opens International Lounge to Enhance Cross-border Care
Fortis Memorial Research Institute Gives Heart Patient a New Lease of Life
Gleneagles Hospital, Mumbai Successfully Treats India’s Youngest POEM Patient
Our team helped an underweight 14-month-old child with a rare swallowing disorder restore the ability to eat and gain weight normally through the minimally invasive procedure.
